Cat. #151577
OGG1 KO Mouse
Cat. #: 151577
Sub-type: Mouse
Availability: 6-8 weeks
Disease: Lung cancer
Model: Knock-Out
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Tomas Lindahl
Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Tool name: OGG1 KO Mouse
- Research fields: Cancer;Genetics
- Tool sub type: Mouse
- Disease: Lung cancer
- Model: Knock-Out
- Conditional: No
- Description: OGG1 defect together with MYH defect causes greatly increased frequency of lung cancer. Knockout mice have been generated deficient in the OGG1 DNA glycosylase that excises the most frequent mutagenic oxidative base lesion, 8-oxoG. It has been shown that (i) 8-oxoG residues accumulate in the genome to substantially increased levels in the nonproliferating liver of ogg1 null mice; (ii) there is no excision of 8-oxoG initiated by a different DNA glycosylase in cell-free tissue extracts, but there is significant slow repair in an ogg1 null cell line; (iii) the in vivo spontaneous mutation frequency is increased (2- to 3-fold) in liver but not in more rapidly proliferating testis; and (iv) ogg1 null mice do not show an increased tumor incidence, although inactivating mutations in the OGG1 gene have been documented in a small number of sporadic human lung, kidney, gastric, and head-and-neck tumors.
- Genetic background: Briefly, a partial murine OGG1 cDNA clone was isolated by reverse transcription PCR and used to screen a mouse 129SV lambda genomic library. Approximately 4.6 kb of genomic DNA including this motif were replaced by the neomycin-resistance gene/polyadenylation signal (Neo) in the targeting construct by cloning a flanking 3.1-kb XhoI fragment (5') into the XhoI site of pSK-MC1-NEO-poly(A) and a flanking 4.7-kb HindIII fragment (3') into the BamHI site. The targeting vector was electroporated into GK129 embryonic stem (ES) cells from 129SV mice. An ES clone in which homologous recombination had occurred in one allele of the ogg1 gene was expanded from a duplicate plate and injected into blastocysts from C57BL/6J mice. Resultant chimeras were mated and agouti F1 progeny were screened by tail biopsy. Mice heterozygous for the targeted ogg1 allele (+/-) were interbred, and F2 progeny were genotyped.
- Phenotype: Homozygous -/- mutant mice indistinguishable from their +/- heterozygous and +/+ wild-type siblings
- Production details: Briefly, a partial murine OGG1 cDNA clone was isolated by reverse transcription PCR and used to screen a mouse 129SV lambda genomic library. Approximately 4.6 kb of genomic DNA including this motif were replaced by the neomycin-resistance gene/polyadenylation signal (Neo) in the targeting construct by cloning a flanking 3.1-kb XhoI fragment (5') into the XhoI site of pSK-MC1-NEO-poly(A) and a flanking 4.7-kb HindIII fragment (3') into the BamHI site. The targeting vector was electroporated into GK129 embryonic stem (ES) cells from 129SV mice. An ES clone in which homologous recombination had occurred in one allele of the ogg1 gene was expanded from a duplicate plate and injected into blastocysts from C57BL/6J mice. Resultant chimeras were mated and agouti F1 progeny were screened by tail biopsy. Mice heterozygous for the targeted ogg1 allele (+/-) were interbred, and F2 progeny were genotyped.
Handling
- Shipping conditions: Embryo/Spermatoza- Dry Ice
Target Details
- Target: OGG1
Related Tools
- Related tools: MEF OGG1 KO Cell Line
References
- Klungland et al. 1999. Proc Natl Acad Sci U S A. 96(23):13300-5. PMID: 10557315.
- Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage.